Newer glucose-lowering agents including glucagon-like peptide-1 receptor agonists (GLP-1RA) have been increasingly used for treatment in patients with type 2 diabetes
The brand's FAQ content states this is sometimes possible, but notes that a simpler approach is often preferred, and that the clinician prioritizes the most appropriate therapy for each patient's goals rather than defaulting to combining everything available
Certain people should avoid glutathione IV therapy, including pregnant or breastfeeding women, people with severe kidney disease, and those with known allergies to any components in the IV solution
The peptide GLP-1 is produced by the enteroendocrine L-cells of the small intestine as a cleavage product of the pre-proglucagon gene within minutes in response to oral glucose or fat
Ringseis R, Wen G, Eder K
At 48 weeks, 93% of participants taking 12 mg achieved normal liver fat levels (below 5%), with an average 86% reduction in liver fat from baseline